| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.6M | +69.2% |
| Cost of Revenue | $9.4M | +54.6% |
| Gross Profit | $23.2M | +75.9% |
| R&D Expense | $4.8M | +81.0% |
| SG&A Expense | $12.4M | -34.1% |
| Operating Income | -$6.2M | +24.6% |
| Pre-tax Income | -$5.8M | +27.2% |
| Income Tax | $366K | +134.4% |
| Net Income | -$6.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.4M | +254.7% |
| Short-term Investments | $493K | -75.3% |
| Accounts Receivable | $3.8M | +60.5% |
| Inventory | $3.2M | +75.5% |
| Current Assets | $32.8M | +140.2% |
| Total Assets | $42.2M | +189.7% |
| Current Liabilities | $10.2M | +85.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | +46.7% |
| Capital Expenditures | $1.4M | +832.8% |
| Investing Cash Flow | $260K | +112.8% |
| Financing Cash Flow | $20.9M | +115.5% |
| Free Cash Flow | -$4.7M | +26.4% |
| +24.1% |
| EPS (Basic) | -$0.16 | +42.9% |
| EPS (Diluted) | -$0.16 | +42.9% |
| Total Liabilities |
| $17.5M |
| +213.5% |
| Stockholders' Equity | $24.7M | +174.9% |